Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age

@inproceedings{Silfverdal2014ImmunologicalPI,
  title={Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age},
  author={Sven Arne Silfverdal and Deepak Assudani and Sherine O Kuriyakose and Olivier Van Der Meeren},
  booktitle={Human vaccines & immunotherapeutics},
  year={2014}
}
The combined diphtheria-tetanus-acellular pertussis-hepatitis B-poliomyelitis/Haemophilus influenza vaccine (DTPa-HBV-IPV/Hib: Infanrix™ hexa, GlaxoSmithKline Vaccines) is used for primary vaccination of infants in a range of schedules world-wide. Antibody persistence after 4 DTPa-HBV-IPV/Hib doses in the first 2 y of life has been documented, but long-term persistence data following the 3, 5, 11-12 months (3-5-11) infant vaccination schedule, employed for example in Nordic countries, are… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

at 3 , 5 and 11 - 12 months of age

C Giambi, A Bella, +6 authors E Madonna
  • 2014

Similar Papers

Loading similar papers…